Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis
- 31 January 2006
- journal article
- Published by Elsevier BV in Microbes and Infection
- Vol. 8 (1), 92-104
- https://doi.org/10.1016/j.micinf.2005.05.023
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine VectorsJournal of Virology, 2004
- Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparationsArchiv für die gesamte Virusforschung, 2003
- Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector BoostingJournal of Virology, 2003
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodiesVaccine, 1999
- Recombinant adenovirus synthesizing cell surface-anchored βhCG induces bioneutralizing antibodies in ratsGene, 1997
- Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccinesVaccine, 1997
- Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control studyThe Lancet, 1996
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Protection against Japanese Encephalitis by Inactivated VaccinesNew England Journal of Medicine, 1988